Price $52.79 |
Market Cap
327.79B
|
Sector Health Care |
Div. Growth
3.30%
|
|
P/E
17.8
|
P/B
4.38
|
P/S
4.78
|
Dividend %
2.70%
|
|
P/CF
816.4
|
P/FCF
15.9
|
Op. Cash Flow
32.29M
|
FCF
3.7
|
|
Op. Margin
28.30%
|
Net Margin
27.70%
|
ROE
27.60%
|
ROI
7.60%
|
|
ROA
11.60%
|
EPS Growth
138.50%
|
Current Ratio
1.4
|
Debt/Equity
58.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Genesis Healthcare Inc (GENN) | $0.19 | - | - | 29.3M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.63 | - | - | 68.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.54 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.19 | - | - | 6M | Strong Buy |
| Castlight Health Inc (CSLT) | $2.03 | - | - | 251.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
